Table 1.
Patient baseline characteristics.
| Categorical variables | Baseline | Continuous variables | Baseline | ||||
|---|---|---|---|---|---|---|---|
| Placebo | Drug | p-value | Placebo | Drug | p-value | ||
| White | 75% (24/32) | 87% (20/23) | 0.33 | Age | 57.67 (11.40) | 55.65 (10.34) | 0.18 |
| Male | 53% (17/32) | 57% (13/23) | 1.00 | ||||
| Chest pain | 31% (10/32) | 9% (2/23) | 0.06 | EPA | 25.05 (14.57) | 16.90 (11.40) | 0.05 |
| Menopause | 93% (14/15) | 60% (6/10) | 0.12 | Phosphorus | 3.35 (0.58) | 3.20 (0.50) | 0.06 |
| Hyperlipid meds | 100% (32/32) | 91% (21/23) | 0.17 | Lp_a | 15.00 (2.75) | 15.00 (34.00) | 0.08 |
| Aspirin | 59% (19/32) | 39% (9/23) | 0.18 | GSP | 296 (170) | 242 (125) | 0.10 |
| Angiogram | 22% (7/32) | 9% (2/23) | 0.28 | Mscl_CK | 121 (103) | 95 (53) | 0.10 |
| Kidney disease | 3% (1/32) | 13% (3/23) | 0.30 | BetaSitosterol | 157 (164) | 131 (103) | 0.12 |
| Angioplasty | 12% (4/32) | 4% (1/23) | 0.39 | Mscl_NTproBNP | 43 (42) | 57 (64) | 0.16 |
| Smoked past | 88% (14/16) | 100% (11/11) | 0.50 | Omega3FAIndex | 2.02 (1.66) | 1.89 (0.98) | 0.22 |
| Heart attack | 3% (1/32) | 9% (2/23) | 0.57 | eGFR | 91 (29) | 97 (21) | 0.23 |
| Lung disease | 9% (3/32) | 4% (1/23) | 0.63 | LDL | 71 (59) | 98 (48) | 0.36 |
| Hypertension | 75% (24/32) | 70% (16/23) | 0.76 | Triglycerides | 199 (86) | 194 (85) | 0.51 |
| Hypertension meds | 78% (25/32) | 74% (17/23) | 0.76 | Cholesterol | 137 (63) | 155 (48) | 0.59 |
| Diabetic | 69% (22/32) | 65% (15/23) | 1.00 | BMI | 32.45 (8.55) | 31.50 (8.45) | 0.64 |
| Diabetic meds | 69% (22/32) | 65% (15/23) | 1.00 | VLDL | 27.5 (16) | 28 (19) | 0.85 |
| FHX | 34% (11/32) | 30% (7/23) | 1.00 | HDL cholesterol | 36.50 (13.50) | 36.00 (12.00) | 0.96 |